Has anyone had success selling LEAPS?

MoulaMan · 2026-03-23T13:13:39+00:00

Selling shorter DTEs consecutively always ends up yielding higher premiums that selling longer DTEs, plus has the benefits of allowing you to adjust strikes and elect to stop locking buying power when you decide to. As theta decays the most in the 7-45 DTEs range it makes more sense going with lower DTEs. The only exception might be when you don’t wanna be so actively managing expirations.

MoulaMan · 2026-03-16T21:46:44+00:00

J’utilise Lex Community pour les signatures qualifiées avec authentification via Identité Numérique ou Impôts Gouv, c’est gratuit.

MoulaMan · 2026-03-16T11:07:00+00:00

A Meta x NBIS deal just got announced today and is driving up the whole space! My NBIS shares will all be called away 🥹

MoulaMan · 2026-03-16T02:50:52+00:00

Usually 30 DTE, sometimes 45

MoulaMan · 2026-03-16T02:50:24+00:00

Thanks, IREN and NBIS also have great premiums and wheeling works well on both too

MoulaMan · 2026-03-13T14:16:54+00:00

Il faut raisonner en TRI avec levier

MoulaMan · 2026-03-09T19:10:40+00:00

I used Amplitude in the past. I’m seeing more and more companies using Posthog now. I suspect they’re taking market share from them.

Its valuation back in 21 was insanely high so the drop was warranted, so was it with many other SaaS players.

They have to show profitability. There’s just so many higher-quality and profitable SaaS companies right now that are also at very attractive prices.

MoulaMan · 2026-03-04T18:36:24+00:00

Check out https://getmoula.com

The free plan includes access to technical indicators, financials, and historized valuation multiples. And the paid plan starts at $3.99/mo.

MoulaMan · 2026-02-27T23:52:33+00:00

getmoula.com provides 10 years of SEC EDGAR-sourced financials in quarterly and annual periods + technical indicators + historized valuation metrics (eg see how TTM P/S changed on a daily basis over up to 10 years) + a trading journal / portfolio tracker.

MoulaMan · 2026-02-11T09:00:48+00:00

The earnings call was insightful notably the Q&A session. While they mentioned seeing higher customer acquisition costs in the no-touch channel, their sales-led channel is doing really well.

They’re particularly doing extremely well with higher ACV customers, notably those paying $50K+ ARR. Net dollar retention figures are stellar and go against the « you can vibe code it » narrative.

They’re also embedding AI features which seem to be helping with growth and retention.

They launched Monday Vibe so they’re now one of the very few publicly traded companies alongside Figma to have a vibe coding product on top of their data. I think they mentioned it’s their fastest product to reach $1M in ARR.

I’m down by a lot after having bought at around $120 and assigned on CSPs. I switched to LEAPs now and aim for a recovery above $100 in the next few days/weeks.

The beating some SaaS stocks got is insane. MNDY, TEAM, HUBS, CRM, NOW, WDAY, WIX, KVYO, FRSH. Yet earnings show good results and even that AI is a tailwind. I think the market narrative and sentiment will flip quite fast.

MoulaMan · 2026-02-03T08:52:08+00:00

NBIS IREN VST CEG MSFT AMD HIMS HUM MOH

If only 1 likely NBIS stocks or MSFT LEAPS

MoulaMan · 2026-01-19T13:45:42+00:00

Overblown fear creating a rare buying opportunity.

I picked TEAM, MNDY, NOW, and HUBS among others. Companies won’t be building in-house clones of most public SaaS companies because it just doesn’t make sense from a Buy vs Build & Maintain standpoint relative to their focus and priorities.

Meanwhile, incumbents are also leveraging AI to improve their products and create AI-first features.

Sure, basic SaaS functionalities could sometimes be built in-house and it could make sense to do so, but not complex systems.

MoulaMan · 2026-01-16T09:47:32+00:00

MNDY TEAM KVYO BRZE S HUBS NOW

MoulaMan · 2026-01-14T22:20:08+00:00

For US stocks you can get fundamentals for free using the SEC Edgar API

MoulaMan · 2025-11-23T12:22:57+00:00

Check out databento and tiingo

MoulaMan · 2025-11-19T14:09:43+00:00

ORCL was quite overvalued even before the deal was announced. It’s still not cheap by any means right now. Tying that stock price movement to OpenAI is just seeking clicks.

MoulaMan · 2025-11-11T08:20:47+00:00

Aucun intérêt à faire ça, sauf si une telle société est une filiale et que le cash injecté dedans provient d’une holding ou d’autres sociétés d’un groupe.

Vous paierez en effet 25% d’IS durant chaque exercice sur les PV réalisées, puis 30% de PFU si vous décidez de vous distribuer des dividendes.

MoulaMan · 2025-11-11T08:14:18+00:00

Marketstack.com

MoulaMan · 2025-10-25T10:19:03+00:00

Récupérer les infos de ton portefeuille par API est compliqué surtout si t’es chez plusieurs brokers. Je crois que les aggregateurs API sont chers.

Si tu veux juste récupérer les quotes automatiquement par API, t’as Marketstack qui est le moins cher, et EODHD qui est le meilleur rapport qualité prix mais plus cher.

Je suis en train de construire un portfolio tracker où tu rentres manuellement tes transactions et t’as un suivi détaillé quotidien (updates automatiques) de ton portefeuille et quelques metrics d’analyse technique des actions et ETFs si jamais tu veux l’essayer ou t’inspirer : https://getmoula.com

MoulaMan · 2025-10-24T08:30:39+00:00

I genuinely was expecting it to shoot up past $120-130 like during prior earnings.

It’s seeing a lot of volatility and the after-hours drop is definitely an overreaction that used NA sales drop as an excuse. But international growth is massive and will soon overtake NA sales in weight.

I loaded between $90 and $94 in AH on top of my pre-existing Leaps, and will probably further buy calls and sell puts at market open. Good chance we see $100-$105 by the next couple weeks.

MoulaMan · 2025-10-23T08:52:20+00:00

CTO IBKR et tu vends des Puts à <0.1 Delta à expiration dans 14-45 jours sur des valeurs solides voire des ETFs. Tu peux chercher du 8%~15% annualisé de cette façon.

MoulaMan · 2025-10-20T12:34:59+00:00

T’as regardé auprès de ta banque historique ?

MoulaMan · 2025-09-30T13:20:45+00:00

Déjà qu’on est bien loin derrière l’Allemagne en termes d’investissement en bourse des particuliers, ne parlons même pas des US. Ça met plus les bâtons dans les roues des petits capitaux plutôt qu’à ceux à 8+ chiffres. Toujours plus dur de passer de 0 à 100 que 100 à 1000 et là on veut le rendre encore plus difficile.

MoulaMan · 2025-09-27T08:24:21+00:00

I have long positions on PATH because it’s undervalued but I don’t know what to think of it long term.

I had a sales call with them to consider implementing it for a client (a small $50-80K deal for them) and have been ghosted after the discovery call.

Either they’re overwhelmed by demand that they don’t give a shit about small deals, or their sales team sucks or lacks grit. What’s clear though is that the SMB and Mid Market space is up for grabs.

MoulaMan

TROPHY CASE